Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions

AIM: To assess the levels of different immune modulators in patients with hepatocellular carcinoma (HCC), in relation to other hepatic diseases. METHODS: Eighty-eight patients were included in the current study and represented patients with HCC (20), liver cirrhosis (28) and chronic hepatitis (CH; 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Zekri, Abdel-Rahman N, El Deeb, Somaya, Bahnassy, Abeer A, Badr, Abeer M, Abdellateif, Mona S, Esmat, Gamal, Salama, Hosny, Mohanad, Marwa, El-dien, Ahmed Esam, Rabah, Shimaa, Abd Elkader, Assmaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859225/
https://www.ncbi.nlm.nih.gov/pubmed/29568203
http://dx.doi.org/10.3748/wjg.v24.i11.1228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859225/
https://www.ncbi.nlm.nih.gov/pubmed/29568203
http://dx.doi.org/10.3748/wjg.v24.i11.1228

Ejemplares similares